entertainment Emraan Hashmi's Awarapan 2 has surpassed several major films at the worldwide box office. The action thriller achieved a worldwide gross of 211.24 crore in 15 days, with 151.84 crore net from India. This places it at the 96th spot globally, beating Don 2 and others. Currently, it is the 5th highest-grossing Bollywood film of 2026 globally. The film aims to surpass Ajay Devgn’s Dhamaal 4 next. 🎬
business Akshay Kumar is aiming for a major post-COVID box office milestone with his upcoming film, Haiwaan. He has released 17 theatrical films since the pandemic started, with a total net collection of 1631.04 crore. To hit the 1700 crore mark, he requires just 68.96 crore from the new release. This goal follows his recent success with Welcome To The Jungle, which earned 137.93 crore. Fans will be watching closely to see if this target is achieved soon.
Indian bank stocks have recently displayed the widest exchange price gap in several decades. This significant fluctuation was observed across various major financial institutions operating within India. The specific data points detail the extreme price swings recorded during the recent trading sessions. This massive gap reflects broader shifts in investor sentiment and market dynamics within the banking sector. Analysts are now closely watching these trends to predict the future trajectory of the sector. 📉
entertainment Suriya's movie, Vishwanath And Sons, is performing strongly despite competition from films like Toxic. On the third Saturday, August 29, the film showed a massive 69% jump in ticket sales within just 4 hours. In total, the drama has already registered 2.76 million tickets on BMS across 14 days. This indicates strong word-of-mouth pulling in good footfalls for the movie. Suriya has surpassed 8 million ticket sales across his three major releases in 2026. 📈
health Atorvastatin reduced the risk of major cardiovascular events by 30% compared to placebo in adults aged 70 or older. The large STAREE trial was conducted in general practices across Australia, involving 9971 independently living adults. After a median follow-up of 5.9 years, the benefit was seen, though disability-free survival did not significantly improve. This research addresses the evidence gap for primary prevention in older adults, with results published in The New England Journal of Medicine. Further research is needed to understand this disconnect between event reduction and overall survival outcomes.
health The Phase 3 LIBREXIA ACS trial did not show that adding milvexian reduced cardiovascular events following acute coronary syndrome (ACS). This study involved 14,194 patients across 44 countries, with final results presented at the ESC Congress 2026. CV death, MI, or stroke was 5.4% in the milvexian group versus 5.1% in the placebo group. Despite demonstrating expected anticoagulation, the drug failed to significantly lower MACE on top of standard antiplatelet therapy. Future trials, like LIBREXIA AF, are examining higher doses in different conditions. 🔬
business The Odyssey has surpassed its break-even point at the worldwide box office, making it a massive hit. The film, directed by Christopher Nolan, is performing strongly in cinemas globally. As of now, the worldwide total stands at $1.458 billion, with domestic gross at $549.5 million. Having a $250 million budget, the epic has earned approximately $833 million in profit over its break-even target. The film, released on July 17, is expected to continue dominating the box office for several more weeks. 🎬
business Vishwanath And Sons has become the 5th highest-grossing Kollywood film in Telugu states. The movie, starring Suriya and Mamitha Baiju, earned a gross of 58.55 crore in the Telugu states over 15 days. This performance significantly boosted the film, which was underperforming in Tamil Nadu. The film had a breakeven target of around 40 crore gross and is expected to cross the 60 crore mark soon. It is also projected to overtake Enthiran for the 4th spot in the rankings. 🚀
entertainment The rom-com film Bethlehem Kudumba Unit has achieved a hit verdict in India after 8 days of release. Starring Nivin Pauly and Mamitha Baiju, it was directed by Girish AD and released during Onam. The film earned a net total of 61.7 crore in India and 75.5 crore overseas by Day 8. Having a budget of 30 crore, the movie has recouped 100% of its investment. The film is currently on track to become a super-hit if it reaches 150% profit.
business The romantic drama 'Hi' opened to a modest collection, earning 1.25 crore net in India on its first day. The film stars Nayanthara and Kavin and was released in Tamil and Telugu languages. On day one, the film had only 786 shows operating across India with a 33% occupancy rate. This opening is significantly lower compared to her previous hits like 'Toxic' and 'Mana Shankara Vara Prasad Garu'. The movie, directed by Vishnu Edavan, is being jointly produced by Zee Studios South, The Rowdy Pictures, and Seven Screen Studios. 📉
business Awarapan 2 has crossed the 150 crore mark at the Indian box office after 15 days of release. The film, starring Emraan Hashmi and Disha Patani, is from Vishesh Bhatt's production. It has garnered a total of 151.04 crore in India with a budget of 45 crore. This massive success shows a 235.6% profit percentage, making it a super-duper hit. It is now vying for more top spots against new competition like Toxic.
j / k or ↑ ↓ to move · space for next